L-(+)-Ergothioneine, a sulfur-containing histidine derivative, is an effective antioxidant[1].
In vitro, L-(+)-Ergothioneine (100μM; 18h) protects RPE cell from Sodium iodate (SI)-induced apoptotic and necrotic cell death in vitro[2]. L-(+)-Ergothioneine (10mM; 24h) modulates the tumor microenvironment to facilitate adjuvant vaccine immunotherapy[3].
In vivo, L-(+)-Ergothioneine (35mg/kg; 7 weeks; p.o.) and L-(+)-Ergothioneine’s combination with metformin attenuates renal dysfunction in type-2 diabetic rat model by activating Nrf2 antioxidant pathway[4]. The antioxidant L-(+)-Ergothioneine (15 and 60mg/kg; 30 days) prevents cystine lithiasis in the Slc7a9-/- mouse model of cystinuria[5]. The supplementation of L-(+)-ergothioneine (70mg/kg; 7 days; p.o.) can protect the livers and kidneys of mice from lipid peroxidation damage caused by ferric-nitrilotriacetate (Fenton reagent)[6].
References:
[1] Chen L, Zhang L, Ye X, Deng Z, Zhao C. Ergothioneine and its congeners: anti-ageing mechanisms and pharmacophore biosynthesis. Protein Cell. 2024 Feb 29;15(3):191-206.
[2] Gu S, Wu S, Lin Z, Han Z, Mo K, Huang H, Li M, Li G, Ouyang H, Wang L. Screening and evaluation of antioxidants for retinal pigment epithelial cell protection: L-ergothioneine as a novel therapeutic candidate through NRF2 activation. Exp Eye Res. 2024 May;242:109862.
[3] Yoshida S, Shime H, Matsumoto M, Kasahara M, Seya T. Anti-oxidative Amino Acid L-ergothioneine Modulates the Tumor Microenvironment to Facilitate Adjuvant Vaccine Immunotherapy. Front Immunol. 2019 Apr 4;10:671.
[4] Dare A, Channa ML, Nadar A. L-ergothioneine and its combination with metformin attenuates renal dysfunction in type-2 diabetic rat model by activating Nrf2 antioxidant pathway. Biomed Pharmacother. 2021 Sep;141:111921.
[5] Mayayo-Vallverdú C, López de Heredia M, Prat E, González L, Espino Guarch M, Vilches C, Muñoz L, Asensi MA, Serra C, Llebaria A, Casado M, Artuch R, Garrabou G, Garcia-Roves PM, Pallardó FV, Nunes V. The antioxidant l-Ergothioneine prevents cystine lithiasis in the Slc7a9-/- mouse model of cystinuria. Redox Biol. 2023 Aug;64:102801.
[6] Deiana M, Rosa A, Casu V, Piga R, Assunta Dessì M, Aruoma OI. L-ergothioneine modulates oxidative damage in the kidney and liver of rats in vivo: studies upon the profile of polyunsaturated fatty acids. Clin Nutr. 2004 Apr;23(2):183-93.
L-(+)-Ergothioneine是一种含硫的组氨酸衍生物,是一种有效的抗氧化剂[1]。
在体外,L-(+)-Ergothioneine (100μM; 18小时)可保护RPE细胞免受碘酸钠(SI)诱导的凋亡和坏死性细胞死亡[2]。L-(+)-Ergothioneine (10mM; 24小时)能够调节肿瘤微环境,从而促进辅助疫苗免疫疗法[3]。
在体内,L-(+)-Ergothioneine (35mg/kg; 7周; 口服)及其与二甲双胍的联合使用可通过激活Nrf2抗氧化途径减轻2型糖尿病大鼠模型的肾功能障碍[4]。抗氧化剂L-(+)-Ergothioneine (15和60mg/kg; 30天)可预防Slc7a9-/-小鼠模型中的胱氨酸尿症导致的胱氨酸结石[5]。L-(+)-Ergothioneine (70mg/kg; 7天; 口服)的补充可保护小鼠肝脏和肾脏免受由铁 - 三乙酸铁(Fenton试剂)引起的脂质过氧化损伤[6]。
















